PERSPECTIVES OF CHONDROITIN SULFATE USE («CHONDROGARD») IN PATIENTS WITH KNEE OSTEOARTHRITIS
About the Authors
E. P. Sharapova
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
N. G. Kashevarova
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
E. A. Taskina
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
L. I. Alekseeva
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
A. M. Lila
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
A. N. Bogdanov
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
S. A. Bozhkova
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
A. A. Bagretsova
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
S. M. Noskov
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
E. A. Grunina
V. A. Nasonova research Institute of rheumatology
Russian Federation
Russian Federation
Moscow
Review
For citations:
Sharapova E.P., Kashevarova N.G., Taskina E.A., Alekseeva L.I., Lila A.M., Bogdanov A.N., Bozhkova S.A., Bagretsova A.A., Noskov S.M., Grunina E.A. PERSPECTIVES OF CHONDROITIN SULFATE USE («CHONDROGARD») IN PATIENTS WITH KNEE OSTEOARTHRITIS. Osteoporosis and Bone Diseases. 2020;23(2):203. (In Russ.)
Views:
336
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
